Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-7-2
|
pubmed:abstractText |
This work shows that butyrobetaine administered to rats in a single dose can be highly effective in elevating L-carnitine levels in all tissues. This ability of butyrobetaine was compared to that of L-carnitine. In an experiment with tracer dose of the compounds, 12 h following administration of [3H]butyrobetaine plasma and tissues contained radioactivity exclusively in L-carnitine and in similar amounts as in the other group of animals receiving L-[3H]carnitine. This was observed both after intraperitoneal and oral administration of the compounds. In the loading experiments 100 mumol [3H]butyrobetaine was administered orally to one group and 100 mumol L-[3H]carnitine to the other group of animals and 12 h later it was found that butyrobetaine caused the same increments in L-carnitine as L-carnitine administration. The increments in the organs of the butyrobetaine-treated group (in decreasing order) were as follows: kidney, 1227 nmol/g vs. 652 nmol/g; liver, 469 nmol/g vs. 258 nmol/g; muscle, 1043 nmol/g vs. 881 nmol/g; plasma, 79.4 nmol/ml vs. 39.3 nmol/ml. Butyrobetaine (100 mumol) caused similar increments when it was administered intraperitoneally. Based on these results butyrobetaine can be considered as a potential agent for L-carnitine supplementation therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
1083
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
135-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2036448-Administration, Oral,
pubmed-meshheading:2036448-Animals,
pubmed-meshheading:2036448-Betaine,
pubmed-meshheading:2036448-Carnitine,
pubmed-meshheading:2036448-Injections, Intraperitoneal,
pubmed-meshheading:2036448-Kidney,
pubmed-meshheading:2036448-Liver,
pubmed-meshheading:2036448-Male,
pubmed-meshheading:2036448-Muscles,
pubmed-meshheading:2036448-Rats,
pubmed-meshheading:2036448-Rats, Inbred Strains,
pubmed-meshheading:2036448-Stereoisomerism
|
pubmed:year |
1991
|
pubmed:articleTitle |
Butyrobetaine is equal to L-carnitine in elevating L-carnitine levels in rats.
|
pubmed:affiliation |
University Medical School, Institute of Biochemistry, Pecs, Hungary.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|